BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 25023159)

  • 1. Hepatitis C virus screening practices and seropositivity among US veterans born during 1945 - 1965.
    Cartwright EJ; Rentsch C; Rimland D
    BMC Res Notes; 2014 Jul; 7():449. PubMed ID: 25023159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDC Screening Recommendation for Baby Boomers and Hepatitis C Virus Testing in the US Military Health System.
    Manjelievskaia J; Brown D; Shriver CD; Zhu K
    Public Health Rep; 2017; 132(5):579-584. PubMed ID: 28768119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disparities in hepatitis C testing in U.S. veterans born 1945-1965.
    Sarkar S; Esserman DA; Skanderson M; Levin FL; Justice AC; Lim JK
    J Hepatol; 2016 Aug; 65(2):259-65. PubMed ID: 27130843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C screening trends in a large integrated health system.
    Linas BP; Hu H; Barter DM; Horberg M
    Am J Med; 2014 May; 127(5):398-405. PubMed ID: 24486288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.
    Smith BD; Morgan RL; Beckett GA; Falck-Ytter Y; Holtzman D; Teo CG; Jewett A; Baack B; Rein DB; Patel N; Alter M; Yartel A; Ward JW;
    MMWR Recomm Rep; 2012 Aug; 61(RR-4):1-32. PubMed ID: 22895429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of hepatitis C virus seropositivity among hospitalized US veterans.
    Austin GE; Jensen B; Leete J; De L'Aune W; Bhatnagar J; Racine M; Braun JE
    Am J Med Sci; 2000 Jun; 319(6):353-9. PubMed ID: 10875289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of State-Level Prevalence of Hepatitis C Virus Infection, US States and District of Columbia, 2010.
    Rosenberg ES; Hall EW; Sullivan PS; Sanchez TH; Workowski KA; Ward JW; Holtzman D
    Clin Infect Dis; 2017 Jun; 64(11):1573-1581. PubMed ID: 28449115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vital signs: evaluation of hepatitis C virus infection testing and reporting - eight U.S. sites, 2005-2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 May; 62(18):357-61. PubMed ID: 23657111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites.
    Smith BD; Teshale E; Jewett A; Weinbaum CM; Neaigus A; Hagan H; Jenness SM; Melville SK; Burt R; Thiede H; Al-Tayyib A; Pannala PR; Miles IW; Oster AM; Smith A; Finlayson T; Bowles KE; Dinenno EA
    Clin Infect Dis; 2011 Oct; 53(8):780-6. PubMed ID: 21921221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of hepatitis C virus in adult population in the Czech Republic - time for birth cohort screening.
    Chlibek R; Smetana J; Sosovickova R; Gal P; Dite P; Stepanova V; Pliskova L; Plisek S
    PLoS One; 2017; 12(4):e0175525. PubMed ID: 28406947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and Clinical Management of Persons with Chronic Hepatitis C Virus Infection - Cherokee Nation, 2012-2015.
    Mera J; Vellozzi C; Hariri S; Carabin H; Drevets DA; Miller A; Reilley B; Essex W; Gahn D; Lyons L; Leston J; Ward JW
    MMWR Morb Mortal Wkly Rep; 2016 May; 65(18):461-6. PubMed ID: 27172175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Birth Cohort Testing for Hepatitis C Virus - Indian Health Service 2012-2015.
    Reilley B; Leston J; Hariri S; Neel L; Rudd M; Galope M; Ward J; Vellozzi C
    MMWR Morb Mortal Wkly Rep; 2016 May; 65(18):467-9. PubMed ID: 27171026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. African americans are less likely to have clearance of hepatitis C virus infection: the findings from recent U.S. population data.
    Mir HM; Stepanova M; Afendy M; Kugelmas M; Younossi ZM
    J Clin Gastroenterol; 2012 Sep; 46(8):e62-5. PubMed ID: 22178959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus screening of high-risk patients in a community hospital emergency department: Retrospective review of patient characteristics and future implications.
    Park JS; Wong J; Cohen H
    PLoS One; 2021; 16(6):e0252976. PubMed ID: 34111200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost Effectiveness of Universal Screening for Hepatitis C Virus Infection in the Era of Direct-Acting, Pangenotypic Treatment Regimens.
    Eckman MH; Ward JW; Sherman KE
    Clin Gastroenterol Hepatol; 2019 Apr; 17(5):930-939.e9. PubMed ID: 30201597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hospital-Based Hepatitis C Screening of Baby Boomers in a Majority Hispanic South Texas Cohort: Successes and Barriers to Implementation.
    Taylor BS; Hanson JT; Veerapaneni P; Villarreal R; Fiebelkorn K; Turner BJ
    Public Health Rep; 2016; 131 Suppl 2(Suppl 2):74-83. PubMed ID: 27168665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C Virus Screening and Care: Complexity of Implementation in Primary Care Practices Serving Disadvantaged Populations.
    Turner BJ; Rochat A; Lill S; Bobadilla R; Hernandez L; Choi A; Guerrero JA
    Ann Intern Med; 2019 Dec; 171(12):865-874. PubMed ID: 31791065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pragmatic Experience with Risk-based versus Universal Hepatitis C Screening in Pregnancy: Detection of Infection and Postpartum Linkage to Care.
    Bushman ET; Subramani L; Sanjanwala A; Dionne-Odom J; Franco R; Owen J; Subramaniam A
    Am J Perinatol; 2021 Sep; 38(11):1109-1116. PubMed ID: 33934324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of alcohol use, race, and viral coinfections on spontaneous HCV clearance in a US veteran population.
    Piasecki BA; Lewis JD; Reddy KR; Bellamy SL; Porter SB; Weinrieb RM; Stieritz DD; Chang KM
    Hepatology; 2004 Oct; 40(4):892-9. PubMed ID: 15382122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease.
    Tsui JI; Vittinghoff E; Shlipak MG; Bertenthal D; Inadomi J; Rodriguez RA; O'Hare AM
    Arch Intern Med; 2007 Jun; 167(12):1271-6. PubMed ID: 17592100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.